A2A adenosine-receptor-mediated facilitation of noradrenaline release in rat tail artery involves protein kinase C activation and βγ subunits formed after α2-adrenoceptor activation

Neurochemistry International

Volumn 51, Issue 1, 2007, Pages 47-56

  Fresco, Paula ^a   Oliveira, Jorge M A ^a   Kunc, Filip ^a   Soares, Ana Sofia ^a   Rocha Pereira, Carolina ^a   Gonçalves, Jorge ^a   Diniz, Carmen ^a  

^a Campus Universitário de Santiago   (Portugal)

Author keywords

2 Adrenoceptor; Subunits; Adenosine A2A receptor; Interaction; Protein kinase C

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR; ADENYLATE CYCLASE; FORSKOLIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; NORADRENALIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; YOHIMBINE; ADENOSINE A2A RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; G PROTEIN BETA GAMMA; G PROTEIN COUPLED RECEPTOR; G-PROTEIN BETA GAMMA; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; ANIMAL; ARTERY; BIOSYNTHESIS; DRUG EFFECT; INNERVATION; METABOLISM; PHYSIOLOGY; SECRETION; SYMPATHETIC NERVE; TAIL; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; WISTAR RAT;

HUMAN ECHOVIRUS 1; RATTUS;

ADENYLATE CYCLASE; ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; ANIMALS; ARTERIES; ENZYME ACTIVATION; GTP-BINDING PROTEIN BETA SUBUNITS; GTP-BINDING PROTEIN GAMMA SUBUNITS; MALE; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; PROTEIN KINASE C; PROTEIN SUBUNITS; RATS; RATS, WISTAR; RECEPTOR CROSS-TALK; RECEPTOR, ADENOSINE A2A; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SYMPATHETIC FIBERS, POSTGANGLIONIC; TAIL;

EID: 34347325173     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.03.009     Document Type: Article

References (60)

1. Albert P.R., and Robillard L. G protein specificity, traffic direction required. Cell. Signal. 14 (2002) 407-418
2. 2A receptor activation and facilitation of long-term potentiation in rat hippocampal slices. Neuroscience 122 (2003) 111-121
3. Asano T., and Ogasawara N. Uncoupling of γ-aminobutiric acid B receptors from GTP-binding proteins by N-ethylmaleimide: effect of N-ethylmaleimide on purified GTP-binding proteins. Mol. Pharmacol. 29 (1986) 244-249
4. + exchanger activity, signalling and significance. Cardiovasc. Res. 57 (2003) 942-952
5. Blumer J.B., Smrcka A.V., and Lanier S.M. Mechanistic pathway and biological roles for receptor-independent activators of G-protein signaling. Pharmacol. Ther. (2007) (Epub ahead of print)
6. Boehm S., and Kubista H. Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol. Rev. 54 (2002) 43-99
7. Clapham D.E., and Neer E.J. G protein βγ subunits. Ann. Rev. Pharmacol. Toxicol. 37 (1997) 167-203
8. i/o protein-coupled receptors. Br. J. Pharmacol. 129 (2000) 1095-1102
9. Dell J.E., Connor J., Chen S., Stebbins E.G., Skiba N.P., Mochly-Rosen D., and Hamm HE. The βγ subunit of heterotrimeric G proteins interacts with RACK1 and two other WD repeat proteins. J. Biol. Chem. 277 (2002) 49888-49895
10. Diniz C., Fresco P., and Gonçalves J. Adenosine receptors involved in the modulation of noradrenaline release in rat tail artery. Eur. J. Pharmacol. 504 (2004) 17-25
11. de Gasparo M., Catt K.J., Inagami T., Wright J.W., and Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52 (2000) 415-472
12. Escribá P.V., and García-Sevilla J.A. Paralell modulation of receptor for activated C kinase 1 and protein kinaseC-α and β isoforms in brains of morphine-treated rats. Br. J. Pharmacol. 127 (1999) 343-348
13. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K.-N., and Linden J. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53 (2001) 527-552
14. 2A-adenosine receptor-mediated facilitation of noradrenaline release in isolated rat tail artey. Br. J. Pharmacol. 136 (2002) 230-236
15. 2A receptors triggers both phospholipase C and adenylate cyclase pathways in rat tail artery. Cardiovasc. Res. 63 (2004) 739-746
16. i protein subtypes regulate a single effector mechanism. Mol. Pharmacol. 40 (1991) 707-711
17. Gibson S.K., and Gilman A.G. Giα and Gβ subunits both define selectivity of G protein activation by α2-adrenergic receptors. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 212-217
18. 2A-purinoceptors. Br. J. Pharmacol. 117 (1996) 156-160
19. 2A adenosine receptor. Eur. J. Med. Chem. 38 (2003) 13-18
20. 2A adenosine receptor is necessary for sustained activation of the ERK/MAP kinase pathway. J. Biol. Chem. 280 (2005) 31898-31905
21. sα-selective G protein antagonists. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 346-351
22. Ibrahimi A., Abumrad N., Maghareie H., Golia M., Shoshani I., Desaubry L., and Johnson R.A. Adenylyl cyclase P-site ligands accelerate differentiation in Ob1771 preadipocytes. Am. J. Physiol. 276 (1999) C487-C496
23. 1 adenosine receptor-mediated inhibition of intracellular calcium signaling in the in vitro ventromedial preoptic nucleus. Neuroscience 106 (2001) 733-743
24. Johnston H., and Majewski H. Prejunctional beta-adrenoceptors in rabbit pulmonary artery and mouse atria: effect of alpha-adrenoceptor blockade and phosphodiesterase inhibition. Br. J. Pharmacol. 87 (1986) 553-562
25. αi/o-coupled receptors?. Life Sci. 73 (2003) 2913-2925
26. Jones D.T., and Reed R.R. Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. J. Biol. Chem. 262 (1987) 14241-14249
27. Kirpekar S.M., Wakade A.R., and Prat J.C. Effect of tetraethylammonium and barium on the release of noradrenaline from the perfused cat spleen by nerve stimulation and potassium. Naunyn Schmiedebergs Arch. Pharmacol. 294 1 (1976) 23-29
28. 2 adrenergic receptor subtypes and G proteins in reconstituted phospholipid vesicles. Biochemistry 30 (1991) 3335-33341
29. Liedtke C.M., Yun C.H., Kyle N., and Wang D. Protein kinase Cε-dependent regulation of cystic fibrosis transmembrane regulator involves binding to a receptor for activated C kinase (RACK1) and RACK1 binding to Na+/H+ exchange regulatory factor. J. Biol. Chem. 277 (2002) 2233-2295
30. 5 subunit at receptors and effectors. J. Biol. Chem. 273 (1998) 34429-34436
31. 1 receptor inhibition. Neuroscience 112 (2002) 319-329
32. Lupica C.R., Cass W.A., Zahniser N.R., and Dunwiddie T.V. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J. Pharmacol. Exp. Ther. 252 (1990) 1134-1141
33. Majewski H., and Rand M.J. An interaction between prejunctional alpha-adrenoceptors and prejunctional beta-adrenoceptors. Eur. J. Pharmacol. 69 (1981) 493-498
34. McCahill A., Warwicker J., Bolger G.B., Houslay M.D., and Yarwood SJ. The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. Mol. Pharmacol. 62 (2002) 1261-1273
35. 2a adenosine receptor. J. Biol. Chem. 276 (2001) 15801-15809
36. 2A receptor. Mol. Pharmacol. 69 (2006) 1083-1094
37. Mochly-Rosen D., and Gordon A.S. Anchoring proteins for protein kinase C°: a means for isozyme selectivity. FASEB J. 12 (1998) 35-42
38. Mukai H., Munekata E., and Higashijima T. G protein antagonists. A novel hydrophobic peptide competes with receptor for G protein binding. J. Biol. Chem. 267 (1992) 16237-16243
39. Myung C.-S., Yasuda H., Liu W.W., Harden T.K., and Garrison J.C. Role in isoprenoid lipids on the heterotrimeric G protein γ subunit in determining effector activation. J. Biol. Chem. 274 (1999) 16595-16603
40. Neer E.J. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80 (1995) 249-257
41. Nelson E.J., Hellevuo K., Yoshimura M., and Tabakoff B. Ethanol-induced phosphorylation and potentiation of the activity of type 7 adenylyl cyclase. Involvement of protein kinase C delta. J. Biol. Chem. 278 (2003) 4452-4460
42. i- and phosphoinositide 3-kinase-dependent ERK activation. J. Biol. Chem. 277 (2002) 20453-20460
43. Queiroz G., Talaia C., and Goncalves J. ATP modulates noradrenaline release by activation of inhibitory P2Y receptors and facilitatory P2X receptors in the rat vas deferens. J. Pharmacol. Exp. Ther. 307 (2003) 809-815
44. Rajanayagam M.A., Musgrave I.F., Rand M.J., and Majewski H. Facilitation of noradrenaline release by isoprenaline is not mediated by angiotensin II in mouse atria and rat tail artery. Arch. Int. Pharmacodyn. Ther. 299 (1989) 185-199
45. Seamon K.B., and Daly J.W. Forskolin: its biological and chemical properties. Adv. Cyclic Nucleotide Prot. Phospor. Res. 20 (1986) 1-150
46. 2A-adenosine receptor in primary human endothelial cells. J. Biol. Chem. 272 (1997) 5792-5799
47. Starke K., Gothert M., and Kilbinger H. Modulation of neurotransmitter release by presynaptic receptors. Physiol. Rev. 69 (1989) 864-989
48. 2A adenosine receptor via a novel interacting protein, translin-associated protein X. Mol. Pharmacol. 70 (2006) 454-466
49. Sunahara R.K., and Taussig R. Isoforms of mammalian adenylyl cyclase, multiplicities of signaling. Mol. Interv. 2 (2002) 168-184
50. 2-adrenoceptors on the modulation of noradrenaline release in the rat vas deferens: possible involvement of a group 2 adenylyl cyclase isoform. Neurochem. Int. 47 (2005) 418-429
51. Tesmer J.J., Sunahara R.K., Gilman A.G., and Sprang S.R. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsα·GTPγ. Science 278 (1997) 1907-1916
52. 2-adrenoceptor-deficient mice. Br. J. Pharmacol. 138 (2003) 1389-1402
53. 3H-noradrenaline overflow from cardiac sympathetic nerves by low Ca and tetraethylammonium. Naunyn Schmiedebergs Arch. Pharmacol. 316 (1981) 273-277
54. Wilkinson S.E., Parker P.J., and Nixon J.S. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem. J. 294 (1993) 335-337
55. Yamane H.K., and Fung B.K. Covalent modifications of G-proteins. Ann. Rev. Pharmacol. Toxicol. 33 (1993) 201-241
56. Yao L., McFarland K., Fan P., Jiang Z., Ueda T., and Diamond I. Adenosine A2a blockade prevents synergy between m-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behaviour in addicted rats. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 7877-7882
57. Yao L., McFarland K., Fan P., Jiang Z., Inoue Y., and Diamond I. Activator of G protein signaling 3 regulates opiate activation of protein kinase A signaling and relapse of heroin-seeking behaviour. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 8746-8751
58. Yao L., Fan P., Jiang Z., Mailliard W.S., Gordon A.S., and Diamond I. Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-βγ dimers. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 14379-14384
59. Zimmermann G., and Taussig R. Protein kinase C alters the responsiveness of adenylyl cyclases to G protein α and βγ subunits. J. Biol. Chem. 271 (1996) 27161-27166
60. 2A adenosine receptor antagonist. J. Pharmacol. Exp. Ther. 276 (1996) 398-404